Mohammed H Alqarni
Overview
Explore the profile of Mohammed H Alqarni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Khatoon Z, Khalid M, Alqarni M, Foudah A, Annadurai S, Wahab S, et al.
J Biomol Struct Dyn
. 2023 Dec;
43(6):2733-2745.
PMID: 38127416
CDK6 is a critical protein involved in the regulation of the cell cycle, playing an important role in the progression from the G1 to S phase. In breast cancer, dysregulation...
12.
Alqarni M, Iqbal M, Foudah A, Aljarba T, Abdel Bar F, Alshehri S, et al.
ACS Omega
. 2023 Oct;
8(42):39928-39935.
PMID: 37901579
Suvorexant (SUV) is a new sedative/hypnotic medicine that is recommended to treat insomnia. It is an important medicine from a forensic point of view due to its sedative/hypnotic and depressant...
13.
Shakeel F, Alam P, Haq N, Alqarni M
ACS Omega
. 2023 Oct;
8(42):39936-39944.
PMID: 37901554
There is a dearth of information in the literature regarding environmentally benign high-performance thin-layer chromatography (HPTLC) methods to determine tenoxicam (TNX). Therefore, designing and validating an HPTLC method to detect...
14.
Alkholifi F, Devi S, Aldawsari M, Foudah A, Alqarni M, Salkini M, et al.
Biomedicines
. 2023 Oct;
11(10).
PMID: 37893109
Researchers are actively exploring potential bioactive compounds to enhance the effectiveness of Lisuride (Lis) in treating Parkinson's disease (PD) over the long term, aiming to mitigate the serious side effects...
15.
Alshehri S, Alsayari A, Wahab S, Alqarni M, Sweilam S, Khalid M
J Biomol Struct Dyn
. 2023 Oct;
42(22):12596-12607.
PMID: 37850684
Phosphodiesterase 10 A (PDE10A) is an enzyme that regulates cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) levels in the brain, particularly in the striatum, which plays a critical...
16.
Alam P, Shakeel F, Iqbal M, Foudah A, Alqarni M, Aljarba T, et al.
ACS Omega
. 2023 Aug;
8(33):30655-30664.
PMID: 37636909
High-performance thin-layer chromatographic (HPTLC) assays for pomalidomide (PMD) measurement are lacking in the published database. Furthermore, eco-friendly stability-indicating analytical assays for PMD measurement are also lacking in the published database....
17.
Foudah A, Alam A, Ayman Salkini M, Ross S, Kumar P, Aldawsari M, et al.
Pharmaceuticals (Basel)
. 2023 Aug;
16(8).
PMID: 37631014
Breast cancer is a deadly disease that affects countless women worldwide. The most conventional treatments for breast cancer, such as the administration of anticancer medications such as letrozole (LTZ), pose...
18.
Aldawsari M, Alkholifi F, Foudah A, Alqarni M, Alam A, Salkini M, et al.
Pharmaceuticals (Basel)
. 2023 Aug;
16(8).
PMID: 37631005
The objective of this study was to develop an innovative gallic-acid (GA) drug delivery system that could be administered transdermally, resulting in enhanced therapeutic benefits and minimal negative consequences. The...
19.
Ghazwani M, Hani U, Alqarni M, Alam A
Gels
. 2023 Jul;
9(7).
PMID: 37504429
This work aimed to overcome the disadvantages of the oral administration of beta-caryophyllene and boost efficiency by developing a nanostructured lipid carrier for topical administration of the drug in skin...
20.
Shakeel F, Alam P, Alqarni M, Haq N, Bar F, Iqbal M
Molecules
. 2023 Jul;
28(13).
PMID: 37446763
Eco-friendly liquid chromatographic methods for measuring ergotamine (EGT) are scant in the published database. Accordingly, the goal of the current study was to develop a high-performance thin-layer chromatography (HPTLC) method...